Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge

Author:

Tew Michelle1ORCID,Willis Michael2,Asseburg Christian3ORCID,Bennett Hayley4,Brennan Alan5,Feenstra Talitha678,Gahn James9,Gray Alastair10,Heathcote Laura5,Herman William H.11,Isaman Deanna12,Kuo Shihchen11,Lamotte Mark13,Leal José10,McEwan Phil4,Nilsson Andreas2,Palmer Andrew J.114,Patel Rishi10,Pollard Daniel5,Ramos Mafalda15,Sailer Fabian16,Schramm Wendelin16,Shao Hui17,Shi Lizheng18,Si Lei1419,Smolen Harry J.9,Thomas Chloe5,Tran-Duy An1ORCID,Yang Chunting12,Ye Wen12,Yu Xueting9,Zhang Ping20,Clarke Philip110

Affiliation:

1. Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia

2. The Swedish Institute for Health Economics, Lund, Sweden

3. ESiOR Oy, Kuopio, Finland

4. Health Economics and Outcomes Research Ltd, Cardiff, UK

5. School of Health and Related Research, University of Sheffield, Sheffield, UK

6. Groningen University, Faculty of Science and Engineering, GRIP, Groningen, The Netherlands

7. Groningen University, UMCG, Groningen, The Netherlands

8. Netherlands Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

9. Medical Decision Modeling Inc., Indianapolis, IN, USA

10. Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK

11. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

12. Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA

13. Global Health Economics and Outcomes Research, Real World Solutions, IQVIA, Zaventem, Belgium

14. Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tasmania, Australia

15. Global Health Economics and Outcomes Research, Real World Solutions, IQVIA, Porto Salvo, Portugal

16. GECKO Institute for Medicine, Informatics and Economics, Heilbronn University, Heilbronn, Germany

17. Department of Pharmaceutical Outcomes and Policy. University of Florida College of Pharmacy. Gainesville, FL, USA

18. Department of Health Policy and Management; Tulane University School of Public Health and Tropical Medicine

19. The George Institute for Global Health, UNSW Sydney, Kensington, Australia

20. Division of Diabetes Translation, Centres for Disease Control and Prevention, Atlanta, GA, USA

Abstract

Background Structural uncertainty can affect model-based economic simulation estimates and study conclusions. Unfortunately, unlike parameter uncertainty, relatively little is known about its magnitude of impact on life-years (LYs) and quality-adjusted life-years (QALYs) in modeling of diabetes. We leveraged the Mount Hood Diabetes Challenge Network, a biennial conference attended by international diabetes modeling groups, to assess structural uncertainty in simulating QALYs in type 2 diabetes simulation models. Methods Eleven type 2 diabetes simulation modeling groups participated in the 9th Mount Hood Diabetes Challenge. Modeling groups simulated 5 diabetes-related intervention profiles using predefined baseline characteristics and a standard utility value set for diabetes-related complications. LYs and QALYs were reported. Simulations were repeated using lower and upper limits of the 95% confidence intervals of utility inputs. Changes in LYs and QALYs from tested interventions were compared across models. Additional analyses were conducted postchallenge to investigate drivers of cross-model differences. Results Substantial cross-model variability in incremental LYs and QALYs was observed, particularly for HbA1c and body mass index (BMI) intervention profiles. For a 0.5%-point permanent HbA1c reduction, LY gains ranged from 0.050 to 0.750. For a 1-unit permanent BMI reduction, incremental QALYs varied from a small decrease in QALYs (−0.024) to an increase of 0.203. Changes in utility values of health states had a much smaller impact (to the hundredth of a decimal place) on incremental QALYs. Microsimulation models were found to generate a mean of 3.41 more LYs than cohort simulation models ( P = 0.049). Conclusions Variations in utility values contribute to a lesser extent than uncertainty captured as structural uncertainty. These findings reinforce the importance of assessing structural uncertainty thoroughly because the choice of model (or models) can influence study results, which can serve as evidence for resource allocation decisions. Highlights The findings indicate substantial cross-model variability in QALY predictions for a standardized set of simulation scenarios and is considerably larger than within model variability to alternative health state utility values (e.g., lower and upper limits of the 95% confidence intervals of utility inputs). There is a need to understand and assess structural uncertainty, as the choice of model to inform resource allocation decisions can matter more than the choice of health state utility values.

Publisher

SAGE Publications

Subject

Health Policy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3